Clinical Trial Update: Taxotere New Indication - Gastric Cancer Treatment Registration Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Taxotere (docetaxel) for gastric cancer has completed, assessing a new indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Sanofi | Conditions: Stomach Neoplasms | Phase 3 | Status: COMPLETED